No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Aidence, ScreenPoint Medical and Thirona Launch Video Series Explaining Medical Imaging AI

Editor: What To Know

  • Future episodes will address the benefits of AI for medical imaging and the development, validation, and certification of AI algorithms for automated image analysis.
  • A recent survey of over 1,000 radiologists and radiology residents found that the more radiologists know about AI, the more likely they are to adopt it rather than fear replacement.
  • Each episode of “Opening the Black Box” covers one specific topic related to AI in medical imaging in approximately 10 minutes.

Aidence, ScreenPoint Medical and Thirona – have launched the
informative video series “Opening the black box of AI in medical imaging”.

Their aim is to close knowledge gaps and increase trust in imaging AI by explaining how this emerging technology can be applied in radiology. The collaboration is unique in the industry.

Solving the “black box” problem: Artificial intelligence is referred to as a “black box” because its inputs and outputs are visible, but not the workings in-between. It is often the cause of public distrust and lack of acceptance.

A recent survey of over 1,000 radiologists and radiology residents found that the more radiologists know about AI, the more likely they are to adopt it rather than fear replacement.

As front-runners in the MedTech industry, Aidence, ScreenPoint Medical and Thirona recognize their role in making AI comprehensible to healthcare professionals. They decided to bring their complementary insights together and answer frequent questions on AI in an innovative way.

One episode at a time: Each episode of “Opening the Black Box” covers one specific topic related to AI in medical imaging in approximately 10 minutes. The videos use a combination of animations and interviews with clinical, data science, regulatory, and industry experts.

The series starts with the basics: a short history of AI and how it differs from machine and deep learning. Mark-Jan Harte, Eva van Rikxoort and Nico Karssemeijer, founders of the three companies, explain what AI means to them.

Watch the first episode here: Future episodes will address the benefits of AI for medical imaging and the development, validation, and certification of AI algorithms for automated image analysis. The series will also show real-world examples of AI deployments and applications in, for example, early breast and lung cancer detection.

Episodes will be made available here over the coming months: https://www.blackboxmed.ai/

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy